CRISPR Therapeutics AG (CRSP): One of The most Shorted Mid Cap Stocks to Buy on Robust Gene Editing Pipeline

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the most shorted mid-cap and small-cap stocks to buy now. On May 27, research firm Citizens reiterated a Market Perform rating and a $60 price target on CRISPR Therapeutics AG (NASDAQ:CRSP).

CRISPR Therapeutics AG (CRSP): One of The most Shorted Mid Cap Stocks to Buy on Robust Gene Editing Pipeline

The stance comes on the heels of the company maintaining a positive view of in vivo editing in cardiovascular disease. Its clinical data, presented at the European Atherosclerosis Society Congress, continues to draw strong interest in gene-editing approaches. That’s because they offer new modalities that can deliver profound and sustained lipid-lowering effects.

The company continues to advance its diversified portfolio of in vivo gene-editing programs, leveraging its proprietary liver-directed LNP delivery platform. For starters, CTX310®, a therapy targeting angiopoietin-like protein 3 (ANGPTL3), is progressing in a Phase 1b clinical trial for severe hypertriglyceridemia (sHTG) and refractory hypercholesterolemia.

CRISPR Therapeutics is also working on CTX460, for the treatment of alpha-1 antitrypsin deficiency (AATD), and CTX340, which targets angiotensinogen (AGT) for refractory hypertension.

CRISPR Therapeutics AG (NASDAQ:CRSP) develops transformative gene-based medicines using CRISPR/Cas9 gene-editing technology. Its core focus is modifying specific genes to correct the underlying causes of serious human diseases, including genetic disorders, cancers, and autoimmune conditions.

While we acknowledge the risk and potential of CRSP as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CRSP and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: Top 10 Small Cap Stocks With Huge Growth Potential and Renaissance Technologies Returns, AUM, CEO and Top 10 Semiconductor Stock Picks.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1